Alternatives to NRG Therapeutics
NRG Therapeutics is a Biotech tool: A biotechnology company developing small molecule drugs to treat neurodegenerative diseases by targeting mitochondrial dysfunction. Here are the 54 closest alternatives, compared on pricing, features and what real users say.
The 20 closest Biotech companies to NRG Therapeutics
AlectorNot ratedBiotechnology company developing immuno-neurology therapies for neurodegenerative diseases.
Amgen3.0 out of 5 (1)A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.
Denali TherapeuticsNot ratedBiopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.
BeiGeneNot ratedA global oncology company developing and commercializing innovative cancer treatments.
Lexeo Therapeutics3.0 out of 5 (1)Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.
ANI PharmaceuticalsNot ratedDiversified biopharmaceutical company focused on rare diseases, generics, and established brands.
Ipsen3.0 out of 5 (1)Global biopharmaceutical company focused on oncology, rare diseases, and neuroscience.
BraeburnNot ratedDevelops long-acting implantable and injectable therapies for opioid addiction and chronic pain.
Alto Neuroscience5.0 out of 5 (1)Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.
Degron TherapeuticsNot ratedClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
EyeGate PharmaceuticalsNot ratedClinical-stage specialty pharmaceutical company developing therapeutics and drug delivery systems for ophthalmic diseases.
Tortugas NeuroscienceNot ratedAdvancing clinical stage pipeline targeting new and major neurology and neuropsychiatric disorders.
Adaptive BiotechnologiesNot ratedLeveraging the adaptive immune system to diagnose and treat disease.
Cradle3.0 out of 5 (1)Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base
Draig TherapeuticsNot ratedClinical-stage biopharmaceutical company developing transformative, best-in-class neuropsychiatric therapies.
BenchSci2.0 out of 5 (2)AI-powered platform for understanding disease biology and accelerating drug discovery.
Manifold BioNot ratedAI-guided drug discovery platform for tissue-targeted medicines.
Aelis FarmaNot ratedClinical-stage biopharmaceutical company developing treatments for brain and peripheral disorders involving the CB1 receptor.
SynthaceNot ratedSynthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.
Cue Biopharma, .Not ratedDeveloping engineered biologics to harness the immune system for disease treatment.
Showing the next 20 closest matches. See the rest on the NRG Therapeutics profile.
Sponsored rows are paid and labelled. Advertise on this page
